Pancreatic cancer in the United States: a retrospective study of incidence patterns
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251271Keywords:
CDC-WONDER, Pancreatic cancer, Trends, Pancreas cancer incidenceAbstract
Background: The seventh most common cause of cancer-related deaths globally is pancreatic cancer. The 5-year survival rate for pancreatic cancer is about 12%, despite advances in its identification and treatment. The present study thus aims to perform an age, gender, race, and state-wise distribution trend analysis of pancreatic cancer incidence in the US from 1999 to 2020.
Methods: The present study is a retrospective research study conducted using the CDC-WONDER database to investigate trends in pancreatic cancer incidence by age, gender, and race from 1999 to 2020. The data was extracted on 18 May 2024, based on temporal trends, demography, and exported to a Microsoft excel sheet. Statistical analysis was done using R version 4.3.1. The figures/graphs were created using GG plot 2, version 3.5.0.
Results: From 1999 to 2020, pancreatic cancer occurred in 919,317 individuals (0.0137%) out of a population of 6,722,531,044, with a crude rate of 13.7 per 100,000. The highest incidence was observed in individuals over 75 years (38.63%), followed by the 65-74 age group (29.02%). Both males and females showed nearly equal incidence rates, while Whites had the highest incidence (83.76%), followed by African Americans (12.22%). Temporal trends indicate increasing incidence overall, particularly among the elderly and Whites, with state-wise highest incidences in California, Florida, and New York.
Conclusion: In summary, the incidence of pancreatic cancer has been increasing for years. Analysis of pancreatic cancer epidemiology and modifiable risk factors can help to determine the preventive measures to reduce pancreatic cancer among the population worldwide.
Metrics
References
Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10-27. DOI: https://doi.org/10.14740/wjon1166
Pompella L, Tirino G, Pappalardo A, Caterino M, Ventriglia A, Nacca V, et al. Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis. Int J Mol Sci. 2020;21(8):2814. DOI: https://doi.org/10.3390/ijms21082814
Lippi G, Mattiuzzi C. The global burden of pancreatic cancer. Arch Med Sci AMS. 2020;16(4):820-4. DOI: https://doi.org/10.5114/aoms.2020.94845
Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27(27):4298-321. DOI: https://doi.org/10.3748/wjg.v27.i27.4298
Powers BD, Fulp W, Dhahri A, DePeralta DK, Ogami T, Rothermel L, et al. The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis. Ann Surg. 2021;274(6):e564-73. DOI: https://doi.org/10.1097/SLA.0000000000003706
Allen WE, Greendyk JD, Alexander HR, Beninato T, Eskander MF, Grandhi MS, et al. Racial disparities in rates of invasiveness of resected intraductal papillary mucinous neoplasms in the United States. Surgery. 2024;175(5):1402-7. DOI: https://doi.org/10.1016/j.surg.2024.01.028
Ryerson AB, Massetti GM. CDC’s Public Health Surveillance of Cancer. Prev Chronic Dis. 2017;14:E39. DOI: https://doi.org/10.5888/pcd14.160480
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. DOI: https://doi.org/10.3322/caac.21442
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913-21. DOI: https://doi.org/10.1158/0008-5472.CAN-14-0155
Hidalgo M. Pancreatic Cancer. N Engl J Med. 2010;362(17):1605-17. DOI: https://doi.org/10.1056/NEJMra0901557
Yadav D, Lowenfels AB. The Epidemiology of Pancreatitis and Pancreatic Cancer. Gastroenterology. 2013;144(6):1252-61. DOI: https://doi.org/10.1053/j.gastro.2013.01.068
Chang KJ, Parasher G, Christie C, Largent J, Anton‐Culver H. Risk of pancreatic adenocarcinoma: Disparity between African Americans and other race/ethnic groups. Cancer. 2005;103(2):349-57. DOI: https://doi.org/10.1002/cncr.20771
Khawja SN, Mohammed S, Silberfein EJ, Musher BL, Fisher WE, Van Buren G. Pancreatic Cancer Disparities in African Americans. Pancreas. 2015;44(4):522-7. DOI: https://doi.org/10.1097/MPA.0000000000000323
Paltoo DN, Chu KC. Patterns in Cancer Incidence among American Indians/Alaska Natives, United States, 1992–1999. Public Health Rep. 2004;119(4):443-51. DOI: https://doi.org/10.1016/j.phr.2004.05.009
Riall TS, Townsend CM, Kuo Y, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: A 2‐Step Process. Cancer. 2010;116(4):930-9. DOI: https://doi.org/10.1002/cncr.24836
Singal V, Singal AK, Kuo YF. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol. 2012;138(4):715-22. DOI: https://doi.org/10.1007/s00432-012-1156-8
Mola J. An Overview of the Updates to the NCCN Guidelines for Pancreatic Cancer. Hirshberg Foundation for Pancreatic Cancer Research. 2023. Available at: https://pancreatic.org/the-hirshberg-foundation-sponsors-the-latest-version-of-the-nccn-guidelines-for-pancreatic-cancer/. Accessed on 21 January 2025.
Downloads
Published
How to Cite
Issue
Section
